Company Overview and News

Closing Bell: Sensex, Nifty close lower; banks drag but FMCG stocks support

2018-04-18 moneycontrol
3:30 pm Market Closing: Benchmark indices closed lower for the first time in last 10 consecutive sessions, dragged by banks. However, the upside in ITC capped losses.

News LIVE: Nordic countries back India#39;s bid for UNSC permanent membership

2018-04-18 moneycontrol
Nordic countries back India's bid for UNSC permanent membership Nordic countries have backed India's bid for permanent membership in a reformed and expanded United Nations Security Council, terming New Delhi as a "strong candidate" for the world body's top organ.

News LIVE: Suresh Prabhu assures exporters of taking up GST refund issue with Fin Min

2018-04-18 moneycontrol
Suresh Prabhu assures exporters of taking up GST refund issue with Fin Min Commerce and Industry Minister Suresh Prabhu today assured exporters of taking up the issue of GST refund with the finance ministry. Exporters are claiming that over 60 per cent of their refunds are still stuck with the government.

Market Live: Sensex erases gains, Nifty below 10,550; banks under pressure

2018-04-18 moneycontrol
1:55 pm Earnings: Mastek's Q4 consolidated net profit increased to Rs 19.4 crore from Rs 18.4 crore and revenue grew by 6.8 percent to Rs 223.7 crore on sequential basis.

News LIVE: 1993 Mumbai blasts death row convict Tahir Merchant dead

2018-04-18 moneycontrol
Seoul to seek deal on formally ending war with N Korea South Korea is seeking to open discussions about formally declaring an end to the war with the nuclear-armed North at a rare inter-Korean summit next week.Both Pyongyang and Seoul claim sovereignty over the whole Korean peninsula, but a treaty could imply mutual recognition of each other.

Market Live: Sensex extends gains, Nifty inches towards 10,600; ITC leads

2018-04-18 moneycontrol
1:18 pm Market Update: Benchmark indices extended gains in afternoon trade, with the Nifty inching towards 10,600 levels on hopes of strong earnings growth.

Market Live: Nifty holds 10,550; FMCG index up 2%, Bharti Group stocks gain

2018-04-18 moneycontrol
12:55 pm Earnings Outlook: "We are looking at Sensex earnings. In Q4, earnings will grow in the range of 13-14 percent, which will be double digit growth after a long time. Partially, this will be due to low base of Q4 last year and the other due to better earnings of global commodity companies, be it energy or metals. That will aid overall growth,” Gaurav Dua, Head of Research, Sharekhan told Moneycontrol.

News LIVE: CBI arrests promoters directors of Diamond Power over Rs 2650 crore bank fraud

2018-04-18 moneycontrol
Bharati Infra,Indus Tower merger soon The merger of Bharti Infratel and Indus Towers is in its final stages and is expected to be completed soon at a value of over 16 billion dollars, reports CNBC TV 18. Bharti Airtel and Vodafone are expected to be the joint promoters of the company with Idea Cellular set to exit its 11.5 percent stake in the Indus Towers to the tune of 1 billion dollars.

NVB PLC sells Idea Cellular shares worth Rs 280 crore

2018-04-17 moneycontrol
NVB plc today sold nearly four crore shares of telecom operator Idea Cellular for Rs 280.57 crore through an open market transaction.

Aditya Birla Group in talks to raise $1 bn for Idea Cellular

2018-04-17 livemint
Mumbai: The Aditya Birla Group is in talks with buyout firms to sell stakes in promoter entities that control Idea Cellular Ltd to raise more than $1 billion, part of which will be used to pay down regulatory dues of the telecom operator ahead of a merger with Vodafone India Ltd, two people directly aware of the development said.

Market Update: Sensex, Nifty rebound as realty stocks outperform; HDFC Bank up 1%; Cipla top Nifty gainer

2018-04-16 moneycontrol
The Indian equity market was trading on a positive note on Monday afternoon with the Nifty adding 33 points and was trading above the 10,500 mark at 10,513 while the Sensex was up 95 points or 0.28 percent.

Vodafone-Idea may give pink slips to 5000 employees

2018-04-16 moneycontrol
The merger of Vodafone India and Idea Cellular may now become a nightmare for some of its employees as a major restructuring exercise is set to take place.

Market Update: CNX IT remains weak as Infosys falls 3%; Tata Motors top loser, falls 5%, Idea at 52-week low

2018-04-16 moneycontrol
The Indian equity market was trading on a negative note on Monday afternoon with the Nifty shedding 12 points and was trading just below the 10,500 mark at 10,468 while the Sensex was down 71 points or 0.21 percent.

Market Update: CNX IT drags as Infosys falls 4%; SBI, ICICI Bank most active, Indiabulls Ventures zooms 16%

2018-04-16 moneycontrol
The Indian equity market was trading on a negative note on Monday morning with the Nifty shedding 13 points and was trading just below the 10,500 mark at 10,467 while the Sensex was down 57 points or 0.17 percent.

Vodafone and Idea may be asked to clear dues worth Rs 19,000 crore before merger

2018-04-13 moneycontrol
As a pre-condition to clear the merger, the Department of Telecommunication (DoT) will soon ask Vodafone India and Idea Cellular to pay bills worth USD 3 billion (approximately Rs 18,870 crore) in relation to pending license fees, spectrum usage charges (SUC) and one-time spectrum charges (OTSC), Economic Times reported.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...